RxDoctor Payments Data

Rahul Doshi, MD

Clinical Cardiac Electrophysiology · Los Angeles, CANPI 1710981766

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Abbott accounts for 61.0% of it on its own, with 31 other manufacturers making up the rest. 2025 is the largest year on record at $121,385, 2.3 times the $53,920 reported in 2019. Among clinical cardiac electrophysiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$469,350in general payments, 2019–2025

Across 1,228 payments — averaging $382.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$286K
  • Boston Scientific$69K
  • ZOLL Respicardia, Inc.$25K
  • Impulse Dynamics (USA) Inc.$19K
  • Cardiofocus, Inc.$14K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$10K
  • plus $46K from 26 others
$1,493,838in research payments, 2019–2025

Across 345 payments — averaging $4329.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$794K
  • Boston Scientific$369K
  • Janssen Research & Development, LLC$108K
  • Impulse Dynamics (USA) Inc.$74K
  • Cardiofocus, Inc.$65K
  • Atricure, Inc.$33K
  • plus $50K from 2 others

What the payments were for

  • Consulting fees$191,84041%
  • Speaking & faculty fees$99,70621%
  • Travel & lodging$109,01623%
  • Food & beverage$68,56815%
  • Education$1030%
  • Entertainment$1170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$469,350 in reported general payments places this provider in the 95th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California

Medicare billing

Part B allowed, 2024
$209,485
Medicare patients
395
Services billed
1,837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$44,342
MultaqDronedarone Hcl16$18,518
Sucralfate58$1,444
Propafenone Hcl ErPropafenone Hcl11$1,062
Pantoprazole Sodium48$898
ClopidogrelClopidogrel Bisulfate44$568
Amiodarone Hcl14$239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$45$44,34254 claims
Sanofi-aventis U.S. LLCMultaq$17$18,51816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 290 clinical cardiac electrophysiology providers in California.

Other clinical cardiac electrophysiology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →